Sun Pharma to announce fourth quarter results on May 30, 2022

Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study Source link

Sun Pharma - Milmet Labs merger Source link

FY20 Q2 Financial Result - Transcript Source link

Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata...

Sun Pharma completes acquisition of Concert Pharmaceuticals Source link

Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules Source link